Ambee Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 49.37 million compared to BDT 38.04 million a year ago. Net income was BDT 1.67 million compared to BDT 0.961 million a year ago. Basic earnings per share from continuing operations was BDT 0.7 compared to BDT 0.4 a year ago.
For the nine months, sales was BDT 155.23 million compared to BDT 145.13 million a year ago. Net income was BDT 3.22 million compared to BDT 1.77 million a year ago. Basic earnings per share from continuing operations was BDT 1.34 compared to BDT 0.74 a year ago.